Shares in Canadian cannabis producers are falling amid reports that the New York Department of Health has banned the sale of cannabis in restaurants and bars. Investors now fear that the legalization of recreational use cannabis in the US is far from certain. Furthermore, the latest figures out of Canada show that the total number of cannabis users did not change significantly following the country's legalization of the drug in October of last year. The market did however receive some good news in the form of reports suggesting that Thailand is considering decriminalizing cannabis. Shares in Canopy Growth Corp. (NYSE:CGC) are demonstrating the best growth in the sector, with investors anticipating the company's entry into the US market. If Canopy Growth succeeds in this ambition, it will most likely "pull up" the shares of some of the smaller players in this sector such as Aphria (TO:APHA), Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY). The latest short-term forecasts from financial scouts predict industry-wide shares growth, with the major players' unit share prices rising to the following levels: Canopy Growth - $46, Tilray - $80, Aurora Canabis Inc. (TO:ACB) - $8, Aphria Inc. (APHA) - $10, and Cronos Group - $20.
Ivan Marchena, Libertex Analyst